Melatonin rescues dopamine neurons from cell death in tissue culture models of oxidative stress

Brain Research

Volumn 768, Issue 1-2, 1997, Pages 317-326

  Iacovitti, Lorraine ^a   Stull, Natalie D ^a   Johnston, Kelly ^a  

^a DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

Dopamine neuron; Melatonin; MPP+; Oxidative stress; Oxyradical; Tissue culture

Indexed keywords

MELATONIN;

ANIMAL CELL; ARTICLE; BRAIN INJURY; CELL DAMAGE; CELL DEATH; DOPAMINE METABOLISM; DOPAMINE RELEASE; DOPAMINERGIC NERVE CELL; NEUROTOXICITY; NEUROTRANSMITTER RELEASE; NONHUMAN; OXIDATIVE STRESS; PARKINSON DISEASE; PRIORITY JOURNAL; TISSUE CULTURE; VENTRAL TEGMENTUM;

ANIMALS; ANTIOXIDANTS; CELL DEATH; CULTURE TECHNIQUES; DOPAMINE; FREE RADICAL SCAVENGERS; IMMUNOENZYME TECHNIQUES; MELATONIN; NEURONS; OXIDATIVE STRESS; RATS; RATS, SPRAGUE-DAWLEY; VITAMIN E;

EID: 0030843476     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(97)00668-9     Document Type: Article

References (49)

1. Barlow-Walden L.R., Reiter R.J., Abe M., Pablos M., Menendez-Pelaez A., Chen L.D., Poeggeler B. Melatonin stimulates brain glutathione peroxidase activity. Neurochem. Int. 26:1995;497-502.
2. Beck K.D., Valverde J., Alexi T., Poulsen K., Moffat B., Vandlen R.A., Rosenthal A., Hefti F. Mesencephalic dopaminergic neurons protected by GDNF from axotomy-induced generation in the adult brain. Nature. 373:1995;339-343.
3. Becker-Andre M., Wiesenberg I., Schaeren-Wiemers N., Andre E., Missbach M., Saurat J.H., Carlberg C. Pineal gland hormone melatonin binds and activates an orphan of the nuclear receptor superfamily. J. Biol. Chem. 289:1994;28531-28534.
4. Ceballos I., Lafon M., Javoy-Agid F.et al. Superoxide dismutase and Parkinson's disease. Lancet. 8696:1990;1035-1036.
5. Chiueh C.C., Huang S.J., Murphy D.L. Suppression of hydroxyl radical formation by MAO inhibitors: a novel possible neuroprotective mechanism in dopaminergic neurotoxicity. J. Neural Transm. 41:1994;189-196.
6. Deng H.X., Hentati A., Tainer J.A., Iqbal Z., Cayabyab A., Hung W.Y., Getzoff E.D., Hu P., Herzfeldt B., Roos R.P., Warner C., Deng G., Soriano E., Smyth C., Parge H.E., Ahmed A., Roses A.D., Hallewell R.A., Pericak-Vance M.A., Siddique T. Amyotrophic lateral sclerosis and structural defects in Cu, ZN superoxide dismutase. Science. 261:1993;1047-1051.
7. +) levels, ascorbic acid oxidation and glutathione levels in the striatal synaptosomes of the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-treated rat. Neurosci. Lett. 161:1993;121-123.
8. Dexter D.T., Carter C.J., Wells F.R., Javoy-Agid F., Javoy-Agid Y., Lees A., Jenner P., Marsden C.D. Basal lipid peroxidation in substantia nigra is increased in Parkinson's disease. J. Neurochem. 52:1989;381-389.
9. Earle K.M. Studies on Parkinson's disease including x-ray fluorescent spectroscopy of formalin fixed brain tissue. J. Neuropathol. Exp. Neurol. 27:1968;1-14.
10. Ehringer H., Hornykiewicz O., Verteilung von Noradrenalin and Dopamin (3-hydroxytyramin) in Gehirn des Menschen und lhr Verhalten bei Erkrankungen des extrapyramidalen Systems. Wien Klin. Wochensch. 38:1960;1236-1239.
11. Fahn S., Cohen G. The oxidant stress hypothesis in Parkinson's disease: evidence supporting it. Ann. Neurol. 32:1992;804-812.
12. Garcia I., Martinou I., Tsujimoto Y., Martinou J.C. Prevention of programmed cell death of sympathetic neurons by the bcl-2 proto-oncogene. Science. 258:1992;302-304.
13. Graham D.G. On the origin and significance of neuromelanin. Arch. Pathol. Lab. Med. 103:1979;359-362.
14. Greenlund L.J.S., Korsmeyer S.J., Johnson E.M. Jr. Role of BCL-2 in the survival and function of developing and mature sympathetic neurons. Neuron. 15:1995;649-661.
15. Greenlund L.J.S., Deckwerth T.L., Johnson E.M. Superoxide dismutase delays neuronal apoptosis: a role for reactive oxygen species in programmed neuronal death. Neuron. 14:1995;303-315.
16. Giusti P., Gusella M., Lipartiti M., Milani D., Zhu W., Vicini S., Manev H. Melatonin protects primary cultures of cerebellar granule neurons from kainate but not from N-methyl-D-aspartate excitotoxicity. Exp. Neurol. 131:1995;39-46.
17. Giusti P., Lipartiti M., Franceschini D., Schiavo N., Floreani M., Manev H. Neuroprotection by melatonin from kainate-induced excitotoxicity in rats. FASEB J. 10:1996;891-896.
18. Heikkila R.E., Hess A., Duvoisin R. Dopaminergic neurotoxicity of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine in mice. Science. 224:1984;1451-1453.
19. Hirsch E.C. Why are nigral catecholaminergic neurons more vulnerable than other cells in parkinson's disease? Ann. Neurol. 32:1992;S88-S93.
20. Hockenbery D.M., Nunez G., Milliman C., Schreiber R.D., Korsmeyer S.J. Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death. Nature. 348:1990;334-336.
21. Hockenbery D.M., Oltvai Z.N., Yin X.M., Milliman C.L., Korsmeyer S.J. Bcl-2 functions in an antioxidant pathway to prevent apoptosis. Cell. 75:1993;241-251.
22. Iacovitti L., Joh T.H., Park I.H., Bunge R.P. Dual expressions of neurotransmitter synthesis in cultured autonomic neurons. J. Neurosci. 1:1981;126-131.
23. Iacovitti L., Evinger M.J., Stull N.D. Muscle-derived differentiation factor increases expression of the tyrosine hydroxylase gene and enzyme activity in cultured DA neurons from the rat midbrain. Mol. Brain Res. 16:1992;215-222.
24. Johnson E.M. Jr., Deckwerth T.L. Molecular mechanisms of developmental neuronal death. Annu. Rev. Neurol. 16:1993;31-46.
25. Kane D.J., Sarafian T.A., Anton R., Hahn H., Gralla E.B., Valentine J.S., Ord T., Bredesen D.E. Bcl-2 inhibition of neural death: decreased generation of reactive oxygen species. Science. 262:1993;1274-1277.
26. Kass G.E., Wright J.M., Nicotera P., Orrenius S. The mechanism of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine toxicity; role of intracellular calcium. Arch. Biochem. Biophys. 260:1988;789-797.
27. Manev H., Cagnoli C.M., Atabay C., Kharlamov E., Ikonomovic M.D., Grayson D.R. Neuronal apoptosis in an in vitro model of photochemically induced oxidative stress. Exp. Neurol. 144:1995;198-206.
28. Melchiorri D., Reiter R.J., Attia A.M., Hara M., Burgos A., Nistico G. Potent protective effect of melatonin on in vivo paraquat-induced oxidative damage in rats. Life Sci. 56:1995;83-89.
29. +) in ventral mesencephalic-striatal co-culture in rat. Neurol. Lett. 170:1994;191-194.
30. Morgan P.J., Barrett P., Howell H.E., Helliwell R. Melatonin receptors: localization, molecular pharmacology and physiological significance. Neurochem. Int. 24:1994;101-146.
31. Pieri C., Marra M., Moroni F., Recchioni R., Marcheselli F. Melatonin: a peroxyl radical scavenger more effective than vitamin E. Life Sci. 55:1994;271-276.
32. B. Poeggeler, S. Saarela, R.J. Reiter, D.-X. Tan, L.D. Chen, L.C. Manchester, L.R. Barlow-Walden, Melatonin - a highly potent endogenous radical scavenger and electron donor: new aspects of the oxidation chemistry of this indole accessed in vitro, Ann. NY Acad. Sci., (1994) 419-421.
33. Poirier J., Dea D., Baccichet A., Thiffault C. Superoxide dismutase expression in Parkinson's disease. Ann. NY Acad. Sci. 738:1994;116-120.
34. Pozo D., Reiter R.J., Calvo J.R., Guerrero J.M. Physiological concentrations of melatonin inhibit nitric oxide synthase in rat cerebellum. Pharm. Lett. 55:1994;455-460.
35. Przedborski S., Kostic V., Jackson-Lewis V., Naini A.B., Simonetti S., Fahn S., Carlson E., Epstein C.J., Cadet J.L. Transgenic mice with increased Cu/Zn-superoxide dismutase activity are resistant to N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity. J. Neurosci. 12:1992;1658-1667.
36. 2-+ homeostasis, cell death, proliferation, and differentiation. Chemico-Biol. Interact. 77:1991;1-23.
37. Robberecht W., Sapp P., Viaene M.K., Rosen D., McKenna-Yasek D., Haines J., Horvitz R., Theys P., Brown R. Jr. Cu/Zn superoxide dismutase activity in familial and sporadic amyotrophic lateral sclerosis. J. Neurochem. 62:1994;384-387.
38. Rosen D.R., Siddique T., Patterson D., Figiewicz D.A., Sapp P., Hentati A., Donaldson D., Goto J., O'Regan J.P., Deng H.X., Rahmani Z., Krizus A., McKenna-Yasek D., Cayabyab A., Gaston S.M., Berger R., Tanzi R.E., Halperin J.J., Herzfeldt B., van den Bergh R., Hung W.-Y., Bird T., Deng G., Mulder D.W., Smyth C., Laing N.G., Soriano E., Pericak-Vance M.A., Haines J., Rouleau G.A., Gusella J.S., Horvitz H.R., Brown R.H. Mutations in Cu/Zn superoxide mismutase gene are associated with familial amyotrophic lateral sclerosis. Nature. 362:1993;59-62.
39. Rothman T.P., Specht L.A., Gershon M.D., Joh T.H., Teitelman G., Pickel V.M., Reis D.J. Catecholamine biosynthetic enzymes are expressed in replicating cells in the peripheral but not the central nervous system. Proc. Natl. Acad. Sci. USA. 77:1980;622-6225.
40. Singer T.P., Castagnoli N. Jr., Ramsay R.R., Trevor A.J. Biochemical events in the development of parkinsonism induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. J. Neurochem. 49:1987;1-8.
41. + induced damage: dependence on initial damage and time of treatment. Brain Res. 640:1994;308-315.
42. Sugden D. Melatonin: binding site characteristics and biochemical and cellular responses. Neurochem. Int. 24:1994;147-157.
43. Tan D.-X., Poeggeler B., Reiter R.J., Chen L.-D., Chen S., Manchester L.C., Barlow-Walden L.R. The pineal hormone melatonin inhibitis DNA-adduct formation induced by the chemical carcinogen safrole in vivo. Cancer Lett. 70:1993;65-71.
44. Tan D.-X., Chen L.-D., Poeggeler B., Manchester L.C., Reiter R.J. Melatonin: a potent, endogenous hydroxyl radical scavenger. Endocr. J. 1:1983;57-60.
45. Toffano G., Savoini G., Aporti F., Calzolari S., Consolazione A., Maura G., Marchi M., Raiteri M., Agnati L.F. The functional recovery of damaged brain: the effect of GM1 monosialoganglioside. J. Neurosci. Res. 12:1984;397-408.
46. Tomac A., Lindqvist E., Lin L.-F.H., Ogren S.O., Young D., Hoffer B.J., Olson L. Protection and repair of the nigrostriatal dopaminergic system by GDNF in vivo. Nature. 373:1995;335-339.
47. C. Tretiakoff, Contribution à l'étude de l'anatomie pathologique du locus niger de soemmering avec quelques deductions relatives a la pathogénie des troubles du tonus musculaire et de la maladie de Parkinson, Jouve and Cie, Paris, 1991.
48. Weisenberg I., Missbach M., Kahlen J.P., Schrader M., Carlberg C. Transcriptional activation of the nuclear receptor RZR by the pineal gland hormone melatonin and identification of CGP 52608 as synthetic gland. Nucl. Acids Res. 23:1995;327-333.
49. + toxicity by deprenyl (selegiline). Ann. NY Acad. Sci. 738:1994;214-221.